Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Omnicom Group
OMC
$24.3B
| $192K | ﹤0.01% |
2,637
+2,481
| +1,590% | +$187K |
2025 Q4
2 quarters
|
|
702
PACCAR
PCAR
$55.7B
| $192K | ﹤0.01% |
1,596
+1
| +0.1% | +$118 |
2021 Q1
21 quarters
|
|
703
SAP
SAP
$274B
| $192K | ﹤0.01% |
1,243
+136
| +12% | +$23.2K |
2015 Q4
42 quarters
|
|
704
Invesco BulletShares 2029 High Yield Corporate Bond ETF
BSJT
$609M
| $191K | ﹤0.01% |
9,046
| – | – |
2023 Q4
10 quarters
|
|
705
Innovator International Developed Power Buffer ETF July
IJUL
$259M
| $191K | ﹤0.01% |
5,309
| – | – |
2025 Q1
5 quarters
|
|
706
Innovator US Equity 10 Buffer ETF Quarterly
ZALT
$841M
| $191K | ﹤0.01% |
+5,628
| New | +$189K |
2026 Q2
0 quarters
|
|
707
Invesco BulletShares 2031 Municipal Bond ETF
BSMV
$211M
| $187K | ﹤0.01% |
8,892
+4
| +0% | +$84 |
2024 Q2
8 quarters
|
|
708
Franklin Templeton
BEN
$18.4B
| $185K | ﹤0.01% |
5,565
+7
| +0.1% | +$210 |
2021 Q2
20 quarters
|
|
709
VanEck Inflation Allocation ETF
RAAX
$1.4B
| $184K | ﹤0.01% |
4,624
+1,816
| +65% | +$74.9K |
2025 Q3
3 quarters
|
|
710
iShares Core Dividend ETF
DIVB
$2.35B
| $183K | ﹤0.01% |
2,966
+2,644
| +821% | +$155K |
2026 Q1
1 quarter
|
|
711
Gen Digital
GEN
$17.7B
| $183K | ﹤0.01% |
7,337
+2,049
| +39% | +$45.8K |
2025 Q1
5 quarters
|
|
712
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $183K | ﹤0.01% |
6,581
+49
| +0.8% | +$1.4K |
2024 Q2
8 quarters
|
|
713
Templeton Emerging Markets Income Fund
TEI
$295M
| $183K | ﹤0.01% |
27,205
| – | – |
2017 Q4
34 quarters
|
|
714
Hartford Strategic Income ETF
HFSI
$1.21B
| $183K | ﹤0.01% |
5,206
| – | – |
2025 Q4
2 quarters
|
|
715
AstraZeneca
AZN
$294B
| $181K | ﹤0.01% |
962
+148
| +18% | +$27.8K |
2020 Q4
22 quarters
|
|
716
Solstice Advanced Materials
SOLS
$10B
| $181K | ﹤0.01% |
2,041
-242
| -11% | -$20K |
2025 Q4
2 quarters
|
|
717
Innovator Growth-100 Power Buffer ETF January
NJAN
$327M
| $180K | ﹤0.01% |
3,058
-696
| -19% | -$40.1K |
2023 Q4
10 quarters
|
|
718
Innovator US Equity Power Buffer ETF April
PAPR
$958M
| $177K | ﹤0.01% |
4,201
+3,129
| +292% | +$130K |
2022 Q2
16 quarters
|
|
719
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.38B
| $176K | ﹤0.01% |
2,613
| – | – |
2023 Q3
11 quarters
|
|
720
First Trust Intermediate Duration Investment Grade Corporate ETF
FIIG
$642M
| $175K | ﹤0.01% |
8,430
-29
| -0.3% | -$602 |
2024 Q2
8 quarters
|
|
721
Franklin Emerging Market Core Dividend Tilt Index ETF
DIEM
$91.4M
| $174K | ﹤0.01% |
4,009
+403
| +11% | +$16.6K |
2025 Q1
5 quarters
|
|
722
TotalEnergies
TTE
$193B
| $174K | ﹤0.01% |
2,236
-43
| -2% | -$3.8K |
2017 Q2
36 quarters
|
|
723
Federated Hermes US Strategic Dividend ETF
FDV
$1.07B
| $173K | ﹤0.01% |
5,520
-13
| -0.2% | -$406 |
2022 Q4
14 quarters
|
|
724
Textron
TXT
$14.5B
| $173K | ﹤0.01% |
1,885
+305
| +19% | +$27.7K |
2023 Q1
13 quarters
|
|
725
Innovator U.S. Small Cap Power Buffer ETF - September
KSEP
$41M
| $173K | ﹤0.01% |
5,607
| – | – |
2025 Q3
3 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.